Atlas Trials

Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features

Clinical trial NCT06449313 · RECRUITING

Trial details

NCT number
NCT06449313
Sponsor
Georgetown University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Stage III
Start date
2026-08-01
Primary completion
2027-12-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.